PABAL

This brand name is authorized in Austria, Estonia, Finland, France, Ireland, Israel, Lithuania, Nigeria, Netherlands, Poland, Romania, Turkey, United Kingdom, South Africa

Active ingredients

The drug PABAL contains one active pharmaceutical ingredient (API):

1 Carbetocin UNII 88TWF8015Y - CARBETOCIN

Carbetocin selectively binds to oxytocin receptors in the smooth muscle of the uterus, stimulates rhythmic contractions of the uterus, increases the frequency of existing contractions, and raises the tone of the uterus musculature. Read about Carbetocin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PABAL Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H01BB03	Carbetocin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01B Posterior pituitary lobe hormones → H01BB Oxytocin and analogues
Discover more medicines within H01BB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1261796
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 129873
Country: FR	Base de données publique des médicaments	Identifier(s): 62023123
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 355558
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8158
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1076900
Country: NG	Registered Drug Product Database	Identifier(s): B4-9085
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 128058
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100162320
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W61784001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8697621750449, 8697621790650
Country: ZA	Health Products Regulatory Authority	Identifier(s): 42/19/0383